Subscribe
Motive Bio, getting closer to a PCOS diagnosis -Episode 6

FemTech Focus

Motive Bio, getting closer to a PCOS diagnosis -Episode 6

Tony Morrison is the Founder and CEO of Motive Bio, a clinical support tool for polycystic ovary syndrome, or PCOS. PCOS is a major cause of infertility and takes an…
April 27, 2020
ADVERTISEMENT
EHRGo-THE FUTURE OF HEALTHCARE EDUCATION

Motive Bio, getting closer to a PCOS diagnosis -Episode 6

Tony Morrison is the Founder and CEO of Motive Bio, a clinical support tool for polycystic ovary syndrome, or PCOS. PCOS is a major cause of infertility and takes an average of 3 years for a woman to be diagnosed. Tony and I discuss why there’s such a lag time in diagnosis and how Motive Bio can empower women to go into their physician’s office prepared with data to help get diagnosed faster. I asked Tony about being a male founder in femtech and what that experience has been like. He gives some really shocking and insightful stories that really got me fired up. Rate, review, and subscribe! Tony Morrison is the Founder and CEO of Motive Bio, a clinical support tool for polycystic ovary syndrome, or PCOS. PCOS is a major cause of infertility and takes an average of 3 years for a woman to be diagnosed. Tony and I discuss why there’s such a lag time in diagnosis and how Motive Bio can empower women to go into their physician’s office prepared with data to help get diagnosed faster. I asked Tony about being a male founder in femtech and what that experience has been like. He gives some really shocking and insightful stories that really got me fired up. Rate, review, and subscribe! 

ADVERTISEMENT
EHRGo-THE FUTURE OF HEALTHCARE EDUCATION

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Proudly supported by:

cover
Medicines360 is constructing healthcare for women everywhere Dr. Jessica Grossman is the CEO of Medicines360, discusses increasing affordability and accessibility in women's health, equity in clinical studies, and demystifying birth control.